Bumrungrad Hospital Public Company Limited
Bumrungrad Hospital Public Company Limited Fundamental Analysis
Bumrungrad Hospital Public Company Limited (BUGDF) shows moderate financial fundamentals with a PE ratio of 16.42, profit margin of 29.81%, and ROE of 25.57%. The company generates $25.2B in annual revenue with weak year-over-year growth of 1.35%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 78.1/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze BUGDF's fundamental strength across five key dimensions:
Efficiency Score
ExcellentBUGDF demonstrates superior asset utilization.
Valuation Score
ExcellentBUGDF trades at attractive valuation levels.
Growth Score
ModerateBUGDF shows steady but slowing expansion.
Financial Health Score
ExcellentBUGDF maintains a strong and stable balance sheet.
Profitability Score
ExcellentBUGDF achieves industry-leading margins.
Key Financial Metrics
Is BUGDF Expensive or Cheap?
P/E Ratio
BUGDF trades at 16.42 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, BUGDF's PEG of -2.38 indicates potential undervaluation.
Price to Book
The market values Bumrungrad Hospital Public Company Limited at 4.04 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 17.17 times EBITDA. This signals the market has high growth expectations.
How Well Does BUGDF Make Money?
Net Profit Margin
For every $100 in sales, Bumrungrad Hospital Public Company Limited keeps $29.81 as profit after all expenses.
Operating Margin
Core operations generate 35.93 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $25.57 in profit for every $100 of shareholder equity.
ROA
Bumrungrad Hospital Public Company Limited generates $20.62 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Bumrungrad Hospital Public Company Limited generates strong operating cash flow of $8.31B, reflecting robust business health.
Free Cash Flow
Bumrungrad Hospital Public Company Limited generates strong free cash flow of $6.29B, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $7.92 in free cash annually.
FCF Yield
BUGDF converts 5.12% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
16.42
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-2.38
vs 25 benchmark
P/B Ratio
Price to book value ratio
4.04
vs 25 benchmark
P/S Ratio
Price to sales ratio
4.89
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.02
vs 25 benchmark
Current Ratio
Current assets to current liabilities
4.60
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.26
vs 25 benchmark
ROA
Return on assets percentage
0.21
vs 25 benchmark
ROCE
Return on capital employed
0.28
vs 25 benchmark
How BUGDF Stacks Against Its Sector Peers
| Metric | BUGDF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 16.42 | 27.91 | Better (Cheaper) |
| ROE | 25.57% | 687.00% | Weak |
| Net Margin | 29.81% | -45285.00% (disorted) | Strong |
| Debt/Equity | 0.02 | 0.33 | Strong (Low Leverage) |
| Current Ratio | 4.60 | 2795.76 | Strong Liquidity |
| ROA | 20.62% | -13557.00% (disorted) | Strong |
BUGDF outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Bumrungrad Hospital Public Company Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
27.63%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
90.21%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
62.34%
Industry Style: Defensive, Growth, Innovation
High Growth